XM tidak menyediakan perkhidmatan kepada penduduk Amerika Syarikat.

Asian shares rise after Fed rate cut, China NPC meeting takes centre stage



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>EMERGING MARKETS-Asian shares rise after Fed rate cut, China NPC meeting takes centre stage</title></head><body>

.

Singapore stocks rise 1.8%

Asian currencies mixed

Philippine stocks heading for third consecutive day of declines

By John Biju and Adwitiya Srivastava

Nov 8 (Reuters) -Most Asian equities advanced on Friday after the U.S. Federal Reserve delivered a widely expected rate cut in a volatile week that saw Donald Trump returning to the White House, with focus now on further stimulus measures from China.

China's week-long National People's Congress Standing Committee meeting concludes later in the day with investors expecting further stimulus measures which could provide support for regional markets.

More stimulus will support emerging market stocks and currencies such that it is fair to call the worst for emerging market assets is over, Poon Panichpibool, a markets strategist at Krung Thai Bank, said.

"But it remains to be seen how big the upsides would be for EM assets amid Trump 2.0."

Trump's victory in the U.S. presidential election has stoked fears that his threat to impose tariffs, especially those on China, would impact most emerging market economies which rely on China as their top trading partner.

Of particular concern for the Philippines, where remittances support a significant portion of growth, is vice presidential candidate JD Vance's proposal for a 10% tax on remittances.

The Philippine peso PHP= declined 0.3%, while equities .PSI retreated 0.4% heading for a third straight day of declines. Shares were on track for the worst week since mid-June.

Most other emerging market equities advanced during the day and for the week, brushing off a fall during the U.S. election, after the U.S. Federal Reserve delivered a rate cut on Thursday.

The Fed signalled a cautious and patient approach to subsequent easing, although analysts still widely believe another rate cut is still on the table in December.

"If the Fed continues to cut rates.... I would expect the EM FXs to regain some strength with some weakness in the U.S. dollar. In this scenario, EM stocks could gain some ground as well," Panichpibool said.

Shares in Indonesia .JKSE jumped 0.9%, while those in Taiwan .TWII climbed 0.6%. Taiwan shares were on track for their best week since mid August.

Stocks in Singapore .STI advanced 1.8% to hit their highest level since November 2007, led by gains in the city-state's top banks following upbeat results.

Shares of the OCBC OCBC.SI, UOB UOBH.SI and DBS DBSM.SI all hit record highs.

Currencies in the region were mixed with the Indonesian rupiah IDR= and the Malaysian ringgit MYR= climbing 0.3% and 0.4%, respectively while the Thai baht THB=TH retreated 0.4%.


HIGHLIGHTS:

** China October bank lending seen declining despite policy measures

** Thailand to pursue new policies to boost and protect digital economy

** With Trump win, India open to freeing up market access for U.S. firms, sources say



Asian stocks and currencies as at 0643 GMT

COUNTRY

FX RIC

FX DAILY %

FX YTD %

INDEX

STOCKS DAILY %

STOCKS YTD %

Japan

JPY=

+0.13

-7.64

.N225

0.24%

18.59%

China

CNY=CFXS

-0.05

-0.72

.SSEC

-0.58

15.99

India

INR=IN

+0.00

-1.38

.NSEI

-0.35

10.96

Indonesia

IDR=

+0.25

-1.88

.JKSE

0.94

0.53

Malaysia

MYR=

+0.41

+4.75

.KLSE

0.10

11.71

Philippines

PHP=

-0.31

-5.09

.PSI

-0.43

8.29

S.Korea

KRW=KFTC

-0.03

-7.10

.KS11

-0.14

-3.55

Singapore

SGD=

-0.13

-0.20

.STI

1.80

15.41

Taiwan

TWD=TP

+0.35

-4.33

.TWII

0.62

31.36

Thailand

THB=TH

-0.38

+0.31

.SETI

-0.65

3.13


Graphic: World FX rates https://tmsnrt.rs/2RBWI5E

Asian stock markets https://tmsnrt.rs/2zpUAr4


Reporting by John Biju in Bengaluru; Editing by Michael Perry, Rashmi Aich and Mrigank Dhaniwala

</body></html>

Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.

Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.

Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.

Amaran Risiko: Modal anda dalam risiko. Produk yang berleveraj mungkin tidak sesuai untuk semua individu. Sila pertimbangkan Pendedahan Risiko kami.